Fetuin B Is a Secreted Hepatocyte Factor Linking Steatosis to Impaired Glucose Metabolism

Cell Metabolism

Volumn 22, Issue 6, 2015, Pages 1078-1089

  Meex, Ruth C ^a   Hoy, Andrew J ^a,h   Morris, Alexander ^a   Brown, Russell D ^a   Lo, Jennifer C Y ^a   Burke, Melissa ^b,c   Goode, Robert J A ^b   Kingwell, Bronwyn A ^d   Kraakman, Michael J ^d   Febbraio, Mark A ^d,e   Greve, Jan Willem ^f   Rensen, Sander S ^f   Molloy, Mark P ^g   Lancaster, Graeme I ^d   Bruce, Clinton R ^a,i   Watt, Matthew J ^a  

^a MONASH UNIVERSITY   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c THE FRANCIS CRICK INSTITUTE   (United Kingdom)

^d BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^e GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^f MAASTRICHT UNIVERSITY   (Netherlands)

^g MACQUARIE UNIVERSITY   (Australia)

^h UNIVERSITY OF SYDNEY   (Australia)

ⁱ DEAKIN UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

FETUIN B; GLUCOSE; INSULIN; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; I KAPPA B KINASE; STRESS ACTIVATED PROTEIN KINASE;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COMMUNICATION; CELL CULTURE; CELLS BY BODY ANATOMY; CELLULAR SECRETION; CLINICAL ARTICLE; CONTROLLED STUDY; FATTY LIVER; GENE SILENCING; GLUCOSE INTOLERANCE; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; HUMAN; INFLAMMATION; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIVER CELL; MALE; MOUSE; MYOTUBE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; SIGNAL TRANSDUCTION; ANIMAL; ANTAGONISTS AND INHIBITORS; BLOOD; C57BL MOUSE; COMPLICATION; CYTOLOGY; DRUG EFFECTS; ENZYMOLOGY; FEMALE; GENETICS; LIPID DIET; LIVER; METABOLISM; MIDDLE AGED; MOUSE MUTANT; PATHOLOGY; RNA INTERFERENCE; UPREGULATION;

ADULT; ALANINE TRANSAMINASE; ANIMALS; ASPARTATE AMINOTRANSFERASES; CELLS, CULTURED; DIABETES MELLITUS, TYPE 2; DIET, HIGH-FAT; FATTY LIVER; FEMALE; FETUIN-B; GLUCOSE; HEPATOCYTES; HUMANS; I-KAPPA B KINASE; INSULIN RESISTANCE; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, OBESE; MIDDLE AGED; RNA INTERFERENCE; UP-REGULATION;

EID: 84951104864     PISSN: 15504131     EISSN: 19327420     Source Type: Journal    
DOI: 10.1016/j.cmet.2015.09.023     Document Type: Article

References (52)

1. M.A. Abdul-Ghani, M. Matsuda, and R.A. DeFronzo Strong association between insulin resistance in liver and skeletal muscle in non-diabetic subjects Diabet. Med. 25 2008 1289 1294
2. B. Ahrén, and G. Pacini Insufficient islet compensation to insulin resistance vs. reduced glucose effectiveness in glucose-intolerant mice Am. J. Physiol. Endocrinol. Metab. 283 2002 E738 E744
3. L.C. Alonso, Y. Watanabe, D. Stefanovski, E.J. Lee, S. Singamsetty, L.C. Romano, B. Zou, A. Garcia-Ocaña, R.N. Bergman, and C.P. O'Donnell Simultaneous measurement of insulin sensitivity, insulin secretion, and the disposition index in conscious unhandled mice Obesity (Silver Spring) 20 2012 1403 1412
4. S. Bellentani, G. Saccoccio, F. Masutti, L.S. Crocè, G. Brandi, F. Sasso, G. Cristanini, and C. Tiribelli Prevalence of and risk factors for hepatic steatosis in Northern Italy Ann. Intern. Med. 132 2000 112 117
5. J.D. Best, S.E. Kahn, M. Ader, R.M. Watanabe, T.C. Ni, and R.N. Bergman Role of glucose effectiveness in the determination of glucose tolerance Diabetes Care 19 1996 1018 1030
6. M.L. Borg, M. Lemus, A. Reichenbach, A. Selathurai, B.J. Oldfield, Z.B. Andrews, and M.J. Watt Hypothalamic neurogenesis is not required for the improved insulin sensitivity following exercise training Diabetes 63 2014 3647 3658
7. J.D. Browning, L.S. Szczepaniak, R. Dobbins, P. Nuremberg, J.D. Horton, J.C. Cohen, S.M. Grundy, and H.H. Hobbs Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity Hepatology 40 2004 1387 1395
8. E.M. Brunt, C.G. Janney, A.M. Di Bisceglie, B.A. Neuschwander-Tetri, and B.R. Bacon Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions Am. J. Gastroenterol. 94 1999 2467 2474
9. S. Chitturi, G.C. Farrell, and J. George Non-alcoholic steatohepatitis in the Asia-Pacific region: future shock? J. Gastroenterol. Hepatol. 19 2004 368 374
10. J.W. Choi, X. Wang, J.I. Joo, D.H. Kim, T.S. Oh, D.K. Choi, and J.W. Yun Plasma proteome analysis in diet-induced obesity-prone and obesity-resistant rats Proteomics 10 2010 4386 4400
11. S. Crowe, L.E. Wu, C. Economou, S.M. Turpin, M. Matzaris, K.L. Hoehn, A.L. Hevener, D.E. James, E.J. Duh, and M.J. Watt Pigment epithelium-derived factor contributes to insulin resistance in obesity Cell Metab. 10 2009 40 47
12. C.P. Day, and O.F. James Steatohepatitis: a tale of two "hits"? Gastroenterology 114 1998 842 845
13. B. Denecke, S. Gräber, C. Schäfer, A. Heiss, M. Wöltje, and W. Jahnen-Dechent Tissue distribution and activity testing suggest a similar but not identical function of fetuin-B and fetuin-A Biochem. J. 376 2003 135 145
14. E. Fabbrini, F. Magkos, B.S. Mohammed, T. Pietka, N.A. Abumrad, B.W. Patterson, A. Okunade, and S. Klein Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity Proc. Natl. Acad. Sci. USA 106 2009 15430 15435
15. S. Fu, J. Fan, J. Blanco, A. Gimenez-Cassina, N.N. Danial, S.M. Watkins, and G.S. Hotamisligil Polysome profiling in liver identifies dynamic regulation of endoplasmic reticulum translatome by obesity and fasting PLoS Genet. 8 2012 e1002902
16. A. Ghazalpour, B. Bennett, V.A. Petyuk, L. Orozco, R. Hagopian, I.N. Mungrue, C.R. Farber, J. Sinsheimer, H.M. Kang, N. Furlotte, and et al. Comparative analysis of proteome and transcriptome variation in mouse PLoS Genet. 7 2011 e1001393
17. D. Greco, A. Kotronen, J. Westerbacka, O. Puig, P. Arkkila, T. Kiviluoto, S. Laitinen, M. Kolak, R.M. Fisher, A. Hamsten, and et al. Gene expression in human NAFLD Am. J. Physiol. Gastrointest. Liver Physiol. 294 2008 G1281 G1287
18. P. Kaur, N.M. Rizk, S. Ibrahim, N. Younes, A. Uppal, K. Dennis, T. Karve, K. Blakeslee, J. Kwagyan, M. Zirie, and et al. iTRAQ-based quantitative protein expression profiling and MRM verification of markers in type 2 diabetes J. Proteome Res. 11 2012 5527 5539
19. A. Kharitonenkov, T.L. Shiyanova, A. Koester, A.M. Ford, R. Micanovic, E.J. Galbreath, G.E. Sandusky, L.J. Hammond, J.S. Moyers, R.A. Owens, and et al. FGF-21 as a novel metabolic regulator J. Clin. Invest. 115 2005 1627 1635
20. I.A. Kirpich, L.N. Gobejishvili, M.B. Homme, S. Waigel, M. Cave, G. Arteel, S.S. Barve, C.J. McClain, and I.V. Deaciuc Integrated hepatic transcriptome and proteome analysis of mice with high-fat diet-induced nonalcoholic fatty liver disease J. Nutr. Biochem. 22 2011 38 45
21. K.M. Korenblat, E. Fabbrini, B.S. Mohammed, and S. Klein Liver, muscle, and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects Gastroenterology 134 2008 1369 1375
22. J. Koska, N. Stefan, P.A. Permana, C. Weyer, M. Sonoda, C. Bogardus, S.R. Smith, D.R. Joanisse, T. Funahashi, J. Krakoff, and J.C. Bunt Increased fat accumulation in liver may link insulin resistance with subcutaneous abdominal adipocyte enlargement, visceral adiposity, and hypoadiponectinemia in obese individuals Am. J. Clin. Nutr. 87 2008 295 302
23. E.W. Kraegen, P.W. Clark, A.B. Jenkins, E.A. Daley, D.J. Chisholm, and L.H. Storlien Development of muscle insulin resistance after liver insulin resistance in high-fat-fed rats Diabetes 40 1991 1397 1403
24. K.G. Kumar, J.L. Trevaskis, D.D. Lam, G.M. Sutton, R.A. Koza, V.N. Chouljenko, K.G. Kousoulas, P.M. Rogers, R.A. Kesterson, M. Thearle, and et al. Identification of adropin as a secreted factor linking dietary macronutrient intake with energy homeostasis and lipid metabolism Cell Metab. 8 2008 468 481
25. K.K. Lai, D. Kolippakkam, and L. Beretta Comprehensive and quantitative proteome profiling of the mouse liver and plasma Hepatology 47 2008 1043 1051
26. D.E. Larson-Meyer, B.R. Newcomer, E. Ravussin, J. Volaufova, B. Bennett, S. Chalew, W.T. Cefalu, and M. Sothern Intrahepatic and intramyocellular lipids are determinants of insulin resistance in prepubertal children Diabetologia 54 2011 869 875
27. K. Linder, F. Springer, J. Machann, F. Schick, A. Fritsche, H.U. Häring, G. Blumenstock, M.B. Ranke, N. Stefan, G. Binder, and S. Ehehalt Relationships of body composition and liver fat content with insulin resistance in obesity-matched adolescents and adults Obesity (Silver Spring) 22 2014 1325 1331
28. R.R. Mason, R. Mokhtar, M. Matzaris, A. Selathurai, G.M. Kowalski, N. Mokbel, P.J. Meikle, C.R. Bruce, and M.J. Watt PLIN5 deletion remodels intracellular lipid composition and causes insulin resistance in muscle Mol. Metab. 3 2014 652 663
29. S.T. Mathews, G.P. Singh, M. Ranalletta, V.J. Cintron, X. Qiang, A.S. Goustin, K.L. Jen, M.J. Charron, W. Jahnen-Dechent, and G. Grunberger Improved insulin sensitivity and resistance to weight gain in mice null for the Ahsg gene Diabetes 51 2002 2450 2458
30. M. Mevorach, A. Giacca, Y. Aharon, M. Hawkins, H. Shamoon, and L. Rossetti Regulation of endogenous glucose production by glucose per se is impaired in type 2 diabetes mellitus J. Clin. Invest. 102 1998 744 753
31. H. Misu, T. Takamura, H. Takayama, H. Hayashi, N. Matsuzawa-Nagata, S. Kurita, K. Ishikura, H. Ando, Y. Takeshita, T. Ota, and et al. A liver-derived secretory protein, selenoprotein P, causes insulin resistance Cell Metab. 12 2010 483 495
32. K. Mori, M. Emoto, H. Yokoyama, T. Araki, M. Teramura, H. Koyama, T. Shoji, M. Inaba, and Y. Nishizawa Association of serum fetuin-A with insulin resistance in type 2 diabetic and nondiabetic subjects Diabetes Care 29 2006 468
33. G.J. Morton, M.E. Matsen, D.P. Bracy, T.H. Meek, H.T. Nguyen, D. Stefanovski, R.N. Bergman, D.H. Wasserman, and M.W. Schwartz FGF19 action in the brain induces insulin-independent glucose lowering J. Clin. Invest. 123 2013 4799 4808
34. Y. Nishida, Y. Higaki, K. Tokuyama, K. Fujimi, A. Kiyonaga, M. Shindo, Y. Sato, and H. Tanaka Effect of mild exercise training on glucose effectiveness in healthy men Diabetes Care 24 2001 1008 1013
35. Y. Oike, M. Akao, K. Yasunaga, T. Yamauchi, T. Morisada, Y. Ito, T. Urano, Y. Kimura, Y. Kubota, H. Maekawa, and et al. Angiopoietin-related growth factor antagonizes obesity and insulin resistance Nat. Med. 11 2005 400 408
36. D. Pal, S. Dasgupta, R. Kundu, S. Maitra, G. Das, S. Mukhopadhyay, S. Ray, S.S. Majumdar, and S. Bhattacharya Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance Nat. Med. 18 2012 1279 1285
37. K.F. Petersen, S. Dufour, D. Befroy, M. Lehrke, R.E. Hendler, and G.I. Shulman Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes Diabetes 54 2005 603 608
38. V.T. Samuel, and G.I. Shulman Mechanisms for insulin resistance: common threads and missing links Cell 148 2012 852 871
39. G.M. Schmid, V. Converset, N. Walter, M.V. Sennitt, K.Y. Leung, H. Byers, M. Ward, D.F. Hochstrasser, M.A. Cawthorne, and J.C. Sanchez Effect of high-fat diet on the expression of proteins in muscle, adipose tissues, and liver of C57BL/6 mice Proteomics 4 2004 2270 2282
40. N. Stefan, and H.U. Häring Circulating fetuin-A and free fatty acids interact to predict insulin resistance in humans Nat. Med. 19 2013 394 395
41. N. Stefan, and H.U. Häring The role of hepatokines in metabolism Nat. Rev. Endocrinol. 9 2013 144 152
42. N. Stefan, A.M. Hennige, H. Staiger, J. Machann, F. Schick, S.M. Kröber, F. Machicao, A. Fritsche, and H.U. Häring Alpha2-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans Diabetes Care 29 2006 853 857
43. L.K. Stewart, Z. Wang, D. Ribnicky, J.L. Soileau, W.T. Cefalu, and T.W. Gettys Failure of dietary quercetin to alter the temporal progression of insulin resistance among tissues of C57BL/6J mice during the development of diet-induced obesity Diabetologia 52 2009 514 523
44. K.J. Strissel, Z. Stancheva, H. Miyoshi, J.W. Perfield 2nd, J. DeFuria, Z. Jick, A.S. Greenberg, and M.S. Obin Adipocyte death, adipose tissue remodeling, and obesity complications Diabetes 56 2007 2910 2918
45. J. Tonelli, P. Kishore, D.E. Lee, and M. Hawkins The regulation of glucose effectiveness: how glucose modulates its own production Curr. Opin. Clin. Nutr. Metab. Care 8 2005 450 456
46. A.A. Toye, M.E. Dumas, C. Blancher, A.R. Rothwell, J.F. Fearnside, S.P. Wilder, M.T. Bihoreau, O. Cloarec, I. Azzouzi, S. Young, and et al. Subtle metabolic and liver gene transcriptional changes underlie diet-induced fatty liver susceptibility in insulin-resistant mice Diabetologia 50 2007 1867 1879
47. N. Turner, G.M. Kowalski, S.J. Leslie, S. Risis, C. Yang, R.S. Lee-Young, J.R. Babb, P.J. Meikle, G.I. Lancaster, D.C. Henstridge, and et al. Distinct patterns of tissue-specific lipid accumulation during the induction of insulin resistance in mice by high-fat feeding Diabetologia 56 2013 1638 1648
48. B.A. Wicklow, K.D. Wittmeier, A.C. MacIntosh, E.A. Sellers, L. Ryner, H. Serrai, H.J. Dean, and J.M. McGavock Metabolic consequences of hepatic steatosis in overweight and obese adolescents Diabetes Care 35 2012 905 910
49. H. Xu, G.T. Barnes, Q. Yang, G. Tan, D. Yang, C.J. Chou, J. Sole, A. Nichols, J.S. Ross, L.A. Tartaglia, and H. Chen Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance J. Clin. Invest. 112 2003 1821 1830
50. Z.M. Younossi, A. Baranova, K. Ziegler, L. Del Giacco, K. Schlauch, T.L. Born, H. Elariny, F. Gorreta, A. VanMeter, A. Younoszai, and et al. A genomic and proteomic study of the spectrum of nonalcoholic fatty liver disease Hepatology 42 2005 665 674
51. M. Zhang, and R. Schekman Cell biology. Unconventional secretion, unconventional solutions Science 340 2013 559 561
52. X. Zhang, J. Yang, Y. Guo, H. Ye, C. Yu, C. Xu, L. Xu, S. Wu, W. Sun, H. Wei, and et al. Functional proteomic analysis of nonalcoholic fatty liver disease in rat models: enoyl-coenzyme a hydratase down-regulation exacerbates hepatic steatosis Hepatology 51 2010 1190 1199